Collaboration agreement will see drugmakers work together on development of new cancer drug
May 11, 2015 at 08:46 AM
1 minute read
The original version of this story was published on Legalweek
Wragge Lawrence Graham & Co and McDermott Will & Emery have won instructions on a $1.3bn (£820m) collaboration deal between AstraZeneca and fellow biopharmaceutical company Innate Pharma.
The agreement will see AstraZeneca and MedImmune, its global biologics research and development arm, work with Innate to accelerate the development of a prospective cancer treatment, IPH2201, which is currently being made by Innate.
Presented by BigVoodoo
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The African Legal Awards recognise exceptional achievement within Africa s legal community during a period of rapid change.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
